Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
First Trust Portfolios L.P. CAAA First Trust Exchange-Traded Fund IV 13G 84.12% 8d
MORGAN STANLEY WIW Western Asset Inflation-Linked Opportunities & Income Fund 13G/A 10.1% 8d
Harraden Circle Investments, LLC TVA Texas Ventures Acquisition III Corp 13G 12.99% 8d
MORGAN STANLEY MDA MDA Space Ltd. 13G/A 0.3% 8d
T. Rowe Price Investment Management, Inc. XENE Xenon Pharmaceuticals Inc. 13G/A 10.3% 8d
First Trust Portfolios L.P. CAAA First Trust Exchange-Traded Fund IV 13G 60.81% 8d
ARK Investment Management LLC TEM Tempus AI, Inc. 13G/A 4.91% 8d
First Trust Portfolios L.P. CAAA First Trust Exchange-Traded Fund IV 13G 85.13% 8d
T. Rowe Price Investment Management, Inc. PCVX Vaxcyte, Inc. 13G/A 11.6% 8d
METEORA CAPITAL, LLC DYNC Dynamix Corp 13G/A 9.15% 8d
Alger Associates, Inc. 13-3017981 ALAI Alger ETF Trust 13G 24.9% 8d
First Trust Portfolios L.P. ACYN First Trust Exchange-Traded Fund 13G 16.05% 8d
First Trust Portfolios L.P. AFGR First Trust Exchange-Traded Fund VIII 13G/A 20.95% 8d
Orbis Investment Management Limited RXO RXO, Inc. 13G/A 13.8% 8d
T. Rowe Price Investment Management, Inc. MSGK MSG Knickerbockers Corp. 13G/A 14.1% 8d
SONA ASSET MANAGEMENT (US) LLC BACC Blue Acquisition Corp 13G/A 0% 8d
First Trust Portfolios L.P. CAAA First Trust Exchange-Traded Fund IV 13G 67.1% 8d
First Trust Portfolios L.P. CAAA First Trust Exchange-Traded Fund IV 13G 65.65% 8d
PRICE T ROWE ASSOCIATES INC /MD/ PACB Pacific Biosciences Of California, Inc. 13G 10.8% 8d
T. Rowe Price Investment Management, Inc. CABA Cabaletta Bio, Inc. 13G/A 13.1% 8d
T. Rowe Price Investment Management, Inc. WBI WaterBridge Infrastructure LLC 13G/A 10.2% 8d
First Trust Portfolios L.P. CAAA First Trust Exchange-Traded Fund IV 13G 49.78% 8d
First Trust Portfolios L.P. CAAA First Trust Exchange-Traded Fund IV 13G 42.81% 8d
First Trust Portfolios L.P. CAAA First Trust Exchange-Traded Fund IV 13G 50.5% 8d
Harraden Circle Investments, LLC ALIS Calisa Acquisition Corp 13G/A 13.89% 8d
FMR LLC ASST Strive, Inc. 13G/A 8.1% 8d
Karpus Management, Inc. MACI Melar Acquisition Corp. I 13G/A 15.83% 8d
JANUS HENDERSON GROUP PLC SGRY Surgery Partners, Inc. 13G/A 4.9% 8d
Capital International Investors AUR Aurora Innovation, Inc. 13G/A 10.3% 8d
Karpus Management, Inc. EWAV East West Ave Acquisition Corp. 13G 16.97% 8d
Capital Research Global Investors D Dominion Energy, Inc 13G/A 10% 8d
FMR LLC OXM Oxford Industries Inc 13G/A 0% 8d
FMR LLC BUYZ Franklin Templeton ETF Trust 13G/A 2.2% 8d
FMR LLC CTVA Corteva, Inc. 13G/A 10.3% 8d
Seventh Hokage Management Limited NIPG NIP Group Inc. 13D 5.9% 8d
FMR LLC COAG Hemab Therapeutics Holdings, Inc. 13G/A 10.4% 8d
FMR LLC BYRN Byrna Technologies Inc. 13G 15% 8d
FMR LLC HLMN Hillman Solutions Corp. 13G/A 10.1% 8d
Coastlands Capital LP BOLT Bolt Biotherapeutics, Inc. 13G 17.5% 8d
Tang Heng NIPG NIP Group Inc. 13D 9.4% 8d
FMR LLC GOSS Gossamer Bio, Inc. 13G 10.9% 8d
Irenic Capital Management LP ARI Apollo Commercial Real Estate Finance Liquidating Trust 13G 6.5% 8d
FMR LLC MMED MiniMed Group, Inc. 13G 13.5% 8d
FMR LLC ACIW Aci Worldwide, Inc. 13G/A 10.1% 8d
COHEN & STEERS, INC. OHI Omega Healthcare Investors Inc 13G/A 10.33% 8d
FMR LLC SFM Sprouts Farmers Market, Inc. 13G/A 9.1% 8d
FMR LLC AVTX Avalo Therapeutics, Inc. 13G/A 0.9% 8d
FMR LLC UPB Upstream Bio, Inc. 13G/A 6.9% 8d
Karpus Management, Inc. EIC Eagle Point Income Co 13G/A 1.25% 8d
FMR LLC NTRA Natera, Inc. 13G/A 10.5% 8d